Our results indicate that CP-P inhibited the NF-κB activation pathway and the expression of various antiapoptotic and proliferative gene products, subsequently inducing apoptosis and suppression of tumor growth in a DMBA-induced breast cancer model. The gene discussed is NFKB1; the disease is neoplasm.